Organ Transplant denials: what the review data shows
Independent reviewers have decided 34 published cases where an insurer denied Organ Transplant — and they overturned the insurer 50% of the time. A denial for Organ Transplant is a starting position, not a final answer.
Conditions behind organ transplant denials
| Category | Decisions | Overturned |
|---|---|---|
| Liver | 7 | 14.3% |
| Cirrhosis | 6 | 66.7% |
| Acute Kidney Failure | 6 | 66.7% |
What the insurer actually argued
| Reason given | Decisions | Overturned |
|---|---|---|
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 29 | 48.3% |
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 5 | 60% |
Where the denial was overturned
The patient is a 59-year-old male who has end-stage COPD requiring continuous supplemental oxygen. He is receiving long-term treatment with steroids and frequent treatment with oral antibiotics. The patient is also Hepatitis C positive. The record indicates the patient has been evaluated for a single lung transplant at two transplant centers and both determined he was not a candidate due to his Hepatitis C status. The patient then consulted with the Cleveland Clinic, which apparently has accepted him as a single lung transplant candidate. This is a patient with end stage lung disease who also has hepatitis C. At issue is whether the patient is a candidate for a lung transplant. Three reasons were stated as to why the patient may not be a candidate despite meeting all other criteria to be listed as a candidate. The prime reason is the presence of Hepatitis C in the patient.
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for immediate referral for a liver transplant. Early liver transplant in the setting of decompensated alcoholic liver disease, defined as before six months of abstinence from alcohol, is recommended for carefully selected patients with severe medically refractory alcohol associated liver disease who are considered to be at low risk for alcohol relapse post-transplant (Crabb, et al.). Weinberg and colleagues reported that early liver transplantation has been successfully performed in patients with severe alcohol associated hepatitis and prior liver decompensation. This patient presents with a history of alcohol use disorder, alcohol withdrawal seizures, chronic pancreatitis, and alcohol-associated hepatitis.
Where the denial was upheld
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested reimbursement for platelet rich plasma. In gynecology, the research on platelet rich plasma therapy is very limited and primarily anecdotal. A recent publication presents a comprehensive review of the use of platelet rich plasma in various gynecologic applications including treatment for refractory endometrium, Asherman's syndrome, poor ovarian response, wound healing, lichen sclerosus, female sexuality issues, vesicovaginal fistula, stress urinary incontinence, and bladder pain syndrome. While the authors acknowledge the potential of platelet rich plasma for these applications, they highlight the need for further studies to confirm its effectiveness and explore its application in other disorders.
The patient is a 68-year-old man with a history of renal failure due to obstructive uropathy, which is likely due to a history of a long-standing enlarged prostate. He wishes to have a kidney transplant. The transplant team recommends he have urologic evaluation, and possible transurethral resection of the prostate (TURP) to decrease the risk of obstructive uropathy effect on the possible kidney transplant. The patient notes he has seen urologists in the past who have recommended he have a TURP procedure, but he has always refused. The patient believes his kidney failure is due to salt overload and he is attempting exercises to help his prostate. The patient does not wish to undergo a TURP procedure as recommended by his provider. He wishes to be listed for kidney transplant without urologic clearance.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.
These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Organ Transplantwhen you appeal: reviewers routinely find that denials like yours didn’t hold up.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY